Notice Number: NOT-AI-17-046

Key Dates
Release Date: October 4, 2017

Issued by
National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform potential applicants that effective immediately, NIAID will no longer be participating in PAR-15-286, "Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02)".

PAR-15-286 has been updated in the following ways to reflect NIAID's withdrawal from this FOA:

Part 1. Overview Information

Components of Participating Organizations

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Cancer Institute (NCI)
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Center for Complementary and Integrative Health (NCCIH)
Office of Dietary Supplements (ODS)
Office of Research on Women’s Health (ORWH)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.865; 93.233; 93.839; 93.838; 93.837; 93.286; 93.273; 93.173; 93.399; 93.396; 93.395; 93.394; 93.393; 93.172; 93.279; 93.879   93.173; 93.242; 93.853    
Part 2. Full Text of Announcement
Section I. Funding Opportunity Description
The following language has been removed from the FOA

NIAID

The mission of the National Institute of Allergy and Infectious Diseases (NIAID) is to conduct and support basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. To accomplish its mission, NIAID conducts and supports a comprehensive portfolio of research on the biology, pathogenesis, and host response to microbes; the mechanisms of normal immune function and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, and transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat the many infectious, immune-mediated, and allergic diseases that afflict people throughout the world.  Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID http://www3.niaid.nih.gov/about/whoWeAre/planningPriorities/.)

Section VII. Agency Contacts

The following contacts have been deleted from the FOA.

Scientific/Research Contact(s)

NIAID
Kenneth E. Santora, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-2933
Email: [email protected]

Matthew J. Fenton, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-496-7291
Email: [email protected]

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Kenneth E. Santora, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-2933
Email: [email protected]

Matthew J. Fenton, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-496-7291
Email: [email protected]